Skip to main content

Table 1 Age, duration of treatment, and biochemical and pharmacological parameters (n = 90)

From: Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

Variables

Median [Range]

Age

62

[48-85]

Year

Tamoxifen duration

571

[84-4380]

Days

E21

9.4

[1.3 - 54.7]

pmol/L

E1

98.6

[29.3 - 355.6]

pmol/L

E1S

582

[30-2923]

pmol/L

FSH

38.2

[20.3 - 108.0]

IU/L

SHBG

81

[27-173]

nmol/L

Tam

96

[31-247]

ng/ml

4OHtam

5.8

[2.7 - 17.2]

ng/ml

4OHNDtam

50.7

[25.1 - 184.8]

ng/ml

NDtam

230

[116-596]

ng/ml

NDDtam

39.8

[15.7 - 93.4]

ng/ml

tamNox

9.6

[3.5 - 37.9]

ng/ml

  1. 1E2, estradiol; E1, estrone; E1S, estrone sulfate; FSH, follicle stimulating hormone; SHBG, sex hormone binding globulin; tam, tamoxifen; 4OHtam, 4-hydroxytamoxifen; 4OHNDtam, 4-hydroxy-N-demethyltamoxifen; NDtam, N-demethyltamoxifen; NDDtam, N-dedimethyltamoxifen; tamNox, tamoxifen-N-oxide.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us